ATE221200T1 - Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten - Google Patents

Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten

Info

Publication number
ATE221200T1
ATE221200T1 AT94914094T AT94914094T ATE221200T1 AT E221200 T1 ATE221200 T1 AT E221200T1 AT 94914094 T AT94914094 T AT 94914094T AT 94914094 T AT94914094 T AT 94914094T AT E221200 T1 ATE221200 T1 AT E221200T1
Authority
AT
Austria
Prior art keywords
autoantibodies
autoantigen
detection
patients
diabetes
Prior art date
Application number
AT94914094T
Other languages
English (en)
Inventor
Steinunn Baekkeskov
Henk-Jan Sophia Child Aanstoot
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE221200T1 publication Critical patent/ATE221200T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT94914094T 1993-04-16 1994-04-08 Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten ATE221200T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4888693A 1993-04-16 1993-04-16
PCT/US1994/003896 WO1994024564A1 (en) 1993-04-16 1994-04-08 Methods for diabetes susceptibility assessment in asymptomatic patients

Publications (1)

Publication Number Publication Date
ATE221200T1 true ATE221200T1 (de) 2002-08-15

Family

ID=21956973

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94914094T ATE221200T1 (de) 1993-04-16 1994-04-08 Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten

Country Status (6)

Country Link
US (2) US6316209B1 (de)
EP (1) EP0693183B1 (de)
JP (1) JP3425149B2 (de)
AT (1) ATE221200T1 (de)
DE (1) DE69431051T2 (de)
WO (1) WO1994024564A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0693183B1 (de) 1993-04-16 2002-07-24 The Regents of the University of California Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten
EP0807253A1 (de) * 1995-01-31 1997-11-19 Novo Nordisk A/S Verfahren zur diagnose der vorklinischen diabetes
US7189516B2 (en) * 2001-08-17 2007-03-13 Luminex Corporation Method for characterizing autoimmune disorders
US8852873B2 (en) 2012-04-13 2014-10-07 Diabetomics, Llc Maternal biomarkers for gestational diabetes
GB201509575D0 (en) * 2015-06-03 2015-07-15 King S College London Diagnostic target
KR20200108015A (ko) 2018-01-10 2020-09-16 브라이트씨드, 인크. 대사를 조절하기 위한 방법
EP4003060A4 (de) 2019-07-29 2023-08-02 Brightseed, Inc. Verfahren zur verbesserung der verdauungsgesundheit
MX2022005682A (es) 2019-11-11 2022-08-08 Brightseed Inc Extracto, producto consumible y método para enriquecer metabolito bioactivo en un extracto.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
NL9001083A (nl) 1990-05-04 1991-12-02 Rijksuniversiteit Beta-cel antigeen.
US5723286A (en) * 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
JP2727377B2 (ja) * 1990-09-07 1998-03-11 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 糖尿病自己抗体の検出方法
US5674692A (en) * 1991-09-06 1997-10-07 Baekkeskov; Steinunn Methods for diabetes susceptibility assessment in asymptomatic patients
EP0693183B1 (de) 1993-04-16 2002-07-24 The Regents of the University of California Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten

Also Published As

Publication number Publication date
DE69431051T2 (de) 2003-03-13
US6960448B2 (en) 2005-11-01
EP0693183B1 (de) 2002-07-24
DE69431051D1 (de) 2002-08-29
WO1994024564A1 (en) 1994-10-27
US6316209B1 (en) 2001-11-13
JPH08509289A (ja) 1996-10-01
JP3425149B2 (ja) 2003-07-07
EP0693183A4 (de) 1998-04-29
EP0693183A1 (de) 1996-01-24
US20050106633A1 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
Bingley et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives
Sowa et al. Athletic participation: Its relationship to student development.
Palfreyman et al. Radioimmunoassay of human myelin basic protein in tissue extract, cerebrospinal fluid and serum and its clinical application to patients with head injury
EP1491889A3 (de) Verfahren zur Unterstützung der Diagnose der Alzheimerschen Krankheit durch Messung der Amyloid-Beta-Peptide(x =41) und Tau
PT1625403E (pt) Método para a previsão, diagnóstico e diagnóstico diferencial de doença de alzheimer
ATE269978T1 (de) Verfahren zur bestimmung der prognose eines patienten mit einer neurologischen krankheit
DE68927459D1 (de) Nachweis einer neurologischen Krankheit oder einer Funktionsstörung
CA2142300A1 (en) Methods for detecting alzheimer's disease
EP0832691A3 (de) Schutzschild für einen Tessttreifen zum Nachweis von Glukose im Blut
SE9103332L (sv) Metod foer diagnos av blodkoagulationssjukdomar
NO982265L (no) Diagnostikk for og mediatorer for inflammatoriske forstyrrelser
ATE221200T1 (de) Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten
DK0568554T3 (da) Fremgangsmåde til påvisning af anti-RNA-antistoffer
BLACK et al. Serum type III procollagen peptide concentrations in systemic sclerosis and Raynaud's phenomenon: relationship to disease activity and duration
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
EP0725277A3 (de) Variable Transskripte von T-Zellen als Marker für Krankheiten
Wright Syphilis and Neanderthal man
DK0788512T3 (da) Proinsulinpeptidforbindelser til detektion og behandling af Type I-diabetes
EP0757105A3 (de) Serumkennzeichenen zur Voraussage von Atemnotsyndrom bei Erwachsenen
MacKenzie et al. Evaluating the abbreviated injury scale
FI951778A0 (fi) Menetelmä allergian toteamiseksi
Reisberg et al. Global deterioration scale
Tull et al. Incidence of childhood-onset IDDM in black African-heritage populations in the Caribbean
ATE229650T1 (de) Verfahren zur diagnose von diabetes und praediabetischer bedingungen
NO20002176D0 (no) Diagnostikk og terapi av kronisk obstruktiv luftveissykdom

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties